Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Declines By 96.4%

VanEck Biotech ETF (NASDAQ:BBH) was the target of a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 800 shares, a decline of 96.4% from the November 30th total of 22,500 shares. Based on an average daily trading volume, of 7,800 shares, the short-interest ratio is currently 0.1 days.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. International Assets Investment Management LLC boosted its position in shares of VanEck Biotech ETF by 10,376,390.9% in the 3rd quarter. International Assets Investment Management LLC now owns 1,141,414 shares of the company’s stock valued at $202,475,000 after purchasing an additional 1,141,403 shares during the period. Jane Street Group LLC raised its position in VanEck Biotech ETF by 401.7% during the third quarter. Jane Street Group LLC now owns 8,348 shares of the company’s stock valued at $1,481,000 after buying an additional 6,684 shares during the period. Atlas Capital Advisors LLC purchased a new stake in VanEck Biotech ETF in the 2nd quarter worth about $960,000. Northwestern Mutual Wealth Management Co. boosted its position in VanEck Biotech ETF by 5.8% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 24,324 shares of the company’s stock worth $4,096,000 after acquiring an additional 1,334 shares during the period. Finally, Wilmington Savings Fund Society FSB purchased a new position in VanEck Biotech ETF during the 3rd quarter valued at about $166,000. Institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Price Performance

Shares of BBH traded down $0.95 during trading hours on Friday, reaching $158.24. 9,084 shares of the company’s stock traded hands, compared to its average volume of 7,332. VanEck Biotech ETF has a twelve month low of $151.35 and a twelve month high of $183.64. The business’s fifty day simple moving average is $166.22 and its two-hundred day simple moving average is $172.47.

VanEck Biotech ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Tuesday, December 24th. Investors of record on Monday, December 23rd were paid a dividend of $1.2517 per share. The ex-dividend date was Monday, December 23rd.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.